Sean Smith, ImmunOs Therapeutics CEO
June 7, 2022 11:05 AM EDT
Financing
Startups

A for­mer Mer­ck di­rec­tor's Pfiz­er-backed biotech will take on his old boss­es in nascent LIL­RB field

Kyle LaHucik

Senior Reporter

On­ly a hand­ful of biotechs are go­ing af­ter LIL­RBs, com­po­nents of the in­nate im­mune sys­tem. But af­ter an ini­tial crop of da­ta out of Mer­ck …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times